This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Suven Life Sciences Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Amol Dinakar Deshpande: Innovator in Pharmaceutical Compounds
Introduction
Amol Dinakar Deshpande is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target histamine H3 receptors. His work is essential for advancing treatments for various disorders related to these receptors.
Latest Patents
Amol holds a patent for "Compounds as histamine H3 receptor ligands." This invention relates to novel compounds of formula (I), along with their pharmaceutically acceptable salts and compositions. The patent also details a process for preparing these compounds, which are useful in treating disorders associated with histamine H receptors. He has 1 patent to his name.
Career Highlights
Amol Dinakar Deshpande is currently associated with Suven Life Sciences Limited, a company known for its innovative approaches in the pharmaceutical industry. His role involves research and development of new therapeutic compounds that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Ramakrishna Nirogi and Anil Karbhari Shinde. Their collaboration has contributed to the advancement of research in the pharmaceutical sector.
Conclusion
Amol Dinakar Deshpande's work in developing histamine H3 receptor ligands showcases his commitment to innovation in pharmaceuticals. His contributions are vital for the ongoing research and development in this important area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile